Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels

A perspective overview is given describing the current development of multiplex mass spectrometry assay technology platforms utilized for high throughput clinical sample analysis. The development of targeted therapies with novel personalized medicine drugs will require new tools for monitoring effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezeli, Melinda, Végvári, Ákos, Fehniger, Thomas E, Laurell, Thomas, Marko-Varga, György
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164614/
https://www.ncbi.nlm.nih.gov/pubmed/21884626
http://dx.doi.org/10.1186/2043-9113-1-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164614/
https://www.ncbi.nlm.nih.gov/pubmed/21884626
http://dx.doi.org/10.1186/2043-9113-1-7

Ejemplares similares